Shareholder rights advocates at levi & korsinsky investigate edwards lifesciences corporation (ew) regarding possible securities fraud violations

New york, ny / accesswire / october 10, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of edwards lifesciences corporation ("edwards lifesciences") (nyse:ew) concerning possible violations of federal securities laws. on october 28, 2022, edwards announced 3q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4q.
EW Ratings Summary
EW Quant Ranking